What Life Science Manufacturing Covers in 2025
Life science manufacturing is no longer a single industry. It is a chain of specialised operations that together turn a research concept into a reproducible, documented product. For a procurement team, the practical question is not who is largest, but which suppliers hold the capability, the quality system and the documentation needed at each stage of that chain.
Research reagents and biochemicals, where purity and lot-to-lot consistency decide experimental reliability.
Custom peptides and oligonucleotides, where synthesis scale and purification capability set the limit.
Small-molecule active ingredients and advanced intermediates for pharmaceutical production.
Culture media, buffers and process aids for biologics and cell-based production.
In-vitro diagnostic reagents, antibodies and device components.
Contract development and manufacturing services covering clinical through commercial supply.
Animal health and agricultural biological inputs.
Qualification Standards Buyers Should Verify
The certificate list below is the minimum evidence package for most regulated life science supply chains. Certificates should be checked for scope, site address and expiry date, not simply collected.
| Supply area | Requirement | Evidence to look for |
|---|---|---|
| General quality management | ISO 9001 | Current certificate with site scope |
| Devices and diagnostics | ISO 13485 | Certificate and regulatory registration status |
| Pharmaceutical ingredients | GMP, ICH Q7 | Audit report and authorised site list |
| Compendial testing | USP, EP and JP monographs | Method validation plus batch certificate of analysis |
| Testing laboratories | ISO 17025 | Accreditation schedule covering the test methods used |
| Environment and safety | ISO 14001, ISO 45001 | Certification and latest audit summary |
| Regulatory filings | DMF and equivalent dossiers | Filing confirmation and current status |
| Chemical compliance | REACH, CLP and equivalent schemes | Registration or exemption statement per substance |
Capability Dimensions That Separate Strong Suppliers
Two manufacturers can hold the same certificate and still differ sharply in day-to-day performance. The dimensions below are the ones that most often decide whether a qualification holds up after the first few orders.
Scale range: ability to supply gram quantities for development and multi-kilogram or tonne lots for commercial supply without changing the process.
Custom synthesis: route design, impurity profiling and control of genotoxic or residual solvents.
Analytical depth: HPLC, GC, LC-MS, ICP-MS and NMR available in-house rather than outsourced, which shortens deviation investigation.
Documentation package: certificate of analysis, safety data sheet, technical data sheet, impurity and stability data supplied as standard rather than on request.
Change control: a formal notification system for raw material, process and site changes.
Business continuity: dual-site or dual-source arrangements for critical raw materials.
Batch consistency: monitored as relative standard deviation of assay across consecutive lots.
Supply Chain and Logistics Considerations
Life science materials are frequently temperature sensitive. Validated shipping configurations, refrigerated or dry-ice shipments and a temperature data logger in every consignment are normal expectations rather than premium options. Packaging performance should be supported by thermal validation data covering the longest realistic transit time in summer and winter conditions.
Customs and transport classification also need attention. Dangerous goods rules under IATA and IMDG regimes govern many solvents, and biological materials may require import or export permits before shipment. Incoterms should be agreed in writing, because responsibility for temperature deviation during transit follows the transfer of risk. Finally, single-source dependencies should be mapped deliberately: for any material that stops production when it is unavailable, a qualified second source is cheaper than an emergency qualification.
Running a Practical Supplier Evaluation
A staged evaluation keeps effort proportional to risk and produces evidence that survives an audit.
Step 1: shortlist suppliers against the required capability and certificate set.
Step 2: issue a structured questionnaire covering quality systems, capacity, lead time and compliance.
Step 3: obtain samples and test at least three lots against your own specification in your own laboratory.
Step 4: conduct a site or remote audit focused on deviation handling, change control and data integrity.
Step 5: place a pilot order with full documentation and a temperature record where relevant.
Step 6: operate a scorecard and review it quarterly with the supplier.
| Key performance indicator | Typical target |
|---|---|
| On-time in-full delivery | 95 percent or higher |
| Batch-to-batch assay relative standard deviation | 1.5 percent or lower |
| Documentation accuracy against specification | 99 percent or higher |
| Complaint acknowledgement within one business day | 95 percent or higher |
| Deviation and corrective action closure within 30 days | 90 percent or higher |
| Stability data available for every catalogue item | Complete coverage |
Frequently Asked Questions
Q: What is the single most important document when qualifying a life science supplier?
The audit report, because certificates confirm that a system exists while an audit shows whether the site actually follows it, particularly in deviation handling and change control.
Q: How many lots should be tested before a supplier is approved?
Three consecutive lots is the common minimum, as it gives a first indication of batch-to-batch consistency rather than a single favourable result.
Q: Does a large manufacturer always outperform a smaller specialist?
No. Large groups usually win on breadth and regulatory filings, while specialists often win on custom synthesis flexibility, shorter lead times and direct technical dialogue.
Q: How should temperature-sensitive materials be shipped?
With a validated packaging configuration and a data logger in the consignment, so that any excursion can be assessed against stability data before the material is released for use.
Q: Which quality metric best predicts long-term supply reliability?
On-time in-full delivery combined with the rate of deviation closure, since together they reflect both logistics control and the health of the quality system.
Q: When should a second source be qualified?
Before it is needed. Qualify a second source for any material that would stop production or a clinical programme if the primary supplier failed.